Skip to content

Company signals, with the date we saw them

Have your competitors watched

Company profiles with the record of what actually changed at each — funding, hiring, expansion, leadership and 100+ other kinds of move, every entry carrying the date we observed it.

Discover millions of companies worldwide

BioGeometry logo — Beijing, China

BioGeometry

China

Beijing, China ·

Where Protein Design Meets Generative AI and Geometric Deep Learning.

Series A 12 Biotechnology
Artificial, Inc. logo — Palo Alto, United States

Artificial, Inc.

United States

Palo Alto, United States ·

Making the digital laboratory accessible to every lab

Series A 14 Robotics
Nutshell Therapeutics logo — Shanghai, China

Nutshell Therapeutics

China

Shanghai, China ·

Deciphering Undruggable by Allostery

Series A 7 Pharmaceutical
48Hour Discovery logo — Edmonton, Canada

48Hour Discovery

Canada

Edmonton, Canada ·

Advancing Peptide Drug Development

Unknown 11 Biotechnology
Analog Devices logo — Wilmington, United States

Analog Devices

United States

Wilmington, United States ·

Global semiconductor leader that bridges the physical and digital worlds to enable breakthroughs at the Intelligent Edge

IPO 27598 Robotics
BELOY logo — France

BELOY

France

France ·

Insurance Reimagined.

Series A 29 Fintech Insurance
Replicate Bioscience, Inc. logo — San Diego, United States

Replicate Bioscience, Inc.

United States

San Diego, United States ·

The Power of RNA Amplified

Series A 24 Biotechnology
Xilis logo — Durham, United States

Xilis

United States

Durham, United States ·

Next generation technologies for drug discovery, development, and precision oncology.

Unknown 14 Biotechnology Pharmaceutical
Seaport Therapeutics logo — Boston, United States

Seaport Therapeutics

United States

Boston, United States ·

We are a clinical-stage therapeutics company advancing the development of novel neuropsychiatric medicines.

Series B 72 Biotechnology Pharmaceutical
Azalea Therapeutics logo — Berkeley, United States

Azalea Therapeutics

United States

Berkeley, United States ·

Redefining precision genomic medicines, in vivo

Series A 31 Biotechnology
Quiver Bioscience logo — Cambridge, United States

Quiver Bioscience

United States

Cambridge, United States ·

Decoding Brain Disease to Reimagine Drug Development

Acquired 47 Biotechnology
NJ Bio, Inc. logo — Princeton, United States

NJ Bio, Inc.

United States

Princeton, United States ·

Integrated Chemistry Solution Provider

Acquired 148 Biotechnology
Foghorn Therapeutics Inc. logo — Watertown, United States

Foghorn Therapeutics Inc.

United States

Watertown, United States ·

Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,

IPO 126 Biotechnology
Parabilis Medicines logo — Cambridge, United States

Parabilis Medicines

United States

Cambridge, United States ·

We are dedicated to creating extraordinary medicines for people affected by serious diseases

Series F+ 197 Biotechnology Pharmaceutical
Cartography Biosciences logo — South San Francisco, United States

Cartography Biosciences

United States

South San Francisco, United States ·

Building a next-generation drug discovery engine to expand the world of treatable cancers.

Unknown 69 Biotechnology
Candid Therapeutics logo — San Diego, United States

Candid Therapeutics

United States

San Diego, United States ·

Developing innovative therapeutics that can materially improve the lives of patients

Acquired 46 Biotechnology Pharmaceutical
Korsana Biosciences logo — Waltham, United States

Korsana Biosciences

United States

Waltham, United States ·

Therapeutics for neurodegenerative diseases targeting amyloid beta

IPO 26 Biotechnology
Helicore Biopharma logo — San Mateo, United States

Helicore Biopharma

United States

San Mateo, United States ·

Long-Acting Medicines to Transform Metabolic Health

Series A 7 Biotechnology Pharmaceutical
Gain Therapeutics logo — Bethesda, United States

Gain Therapeutics

United States

Bethesda, United States ·

Unfolding the next generation of allosteric small molecule therapies to meet patient needs

IPO 26 Biotechnology Pharmaceutical
Ambrosia Biosciences Inc. logo — Boulder, United States

Ambrosia Biosciences Inc.

United States

Boulder, United States ·

Small molecule therapies for obesity and metabolic disorders, delivered orally

Series B 38 Biotechnology Pharmaceutical
Alveus Therapeutics Inc logo — Philadelphia, United States

Alveus Therapeutics Inc

United States

Philadelphia, United States ·

Redefining Weight Management

Series A 34 Biotechnology

From the desk

Want your competitors watched, not just listed?

Our agents watch every move your competitors make. Our analysts tell you what it means and what to do next.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout